# Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD)

> **NCT02725476** · PHASE2 · COMPLETED · sponsor: **Xencor, Inc.** · enrollment: 20 (actual)

## Conditions studied

- IgG4-RD

## Interventions

- **BIOLOGICAL:** XmAb5871

## Key facts

- **NCT ID:** NCT02725476
- **Lead sponsor:** Xencor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02725476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02725476, "Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02725476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*